Award recipients are chosen by committee from nominations from the rare disease community. Fogelberg and Klobuchar were recognized with bronze “Abbey” awards, named for Abbey Meyers, founder of the National Organization for Rare Diseases (NORD). Fogelberg received the Federal Patient Advocacy award. Klobuchar was presented with the Congressional Leadership award.
Fogelberg and Klobuchar, recently achieved a unanimous Senate resolution declaring September 2017 as Pulmonary Fibrosis Awareness Month. They have been instrumental in ensuring that Congress recognizes the contribution of patient advocacy groups that are fighting for individuals with all forms of pulmonary fibrosis.